-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Treatment of aortic stenosis by catheter aortic valve replacement (TAVR) can lead to fragment embolization
Recently, a research paper was published in the top medical journal NEJM, in which researchers randomly assigned patients with aortic stenosis to transfemoral TAVR (CEP group) receiving CEP in a 1:1 ratio and transfemoral TAVR (control group)
3,000 patients from North America, Europe and Australia were randomized; There were 1501 people in the CEP group and 1499 people in the
There was no significant difference in the percentage of patient deaths between the CEP and control groups (0.
It can be seen that in patients with aortic stenosis through femoral TAVR, the use of CEP did not have a significant effect on the incidence of perioperative stroke, but this result did not exclude the benefits of
Original source:
Samir R.
Kapadia.
et al.
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
NEJM.
2022.
